EWTX vs SYRE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EWTX Captures Institutional Edge (3โ1 Pillars ยท 2โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edgewise Therapeutics, Inc. Common Stock (EWTX) driven by superior Valuation, Growth & Margin, Options & Structure while SYRE counters with relative strength in Momentum & Technical. Fundamentally, EWTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SYRE at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EWTX sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro) against SYRE sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EWTX | SYRE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.0B | $9.8B | Larger Scale | SYRE |
| Trailing P/E Ratio Valuation | 5.5x | N/M | Lower Multiple | EWTX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | 92.1% | -35.0% | Higher ROE | EWTX |
| 52-Week Range Position Momentum | 82% ($20โ$49) | 88% ($22โ$111) | Stronger Trend | SYRE |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 74% Vol | 1.75ฮฒ ยท 59% Vol | Lower Realized Risk | SYRE |
| Unified Institutional Score Composite Signal | 35.4 / 100 (SELL) | 44.4 / 100 (HOLD) | Higher Composite | SYRE |